Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Case Study: Enabling tissue engineering through robust process development and manufacturing of key cell types in the lung
Case Study: Development of a human iPSC-derived ALS model
Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs
Case Study: A model of Alzheimer’s disease
Case Study: Manufacturing iPSC-derived skeletal muscle cells
Case study: Development of a cardiac hypertrophy iPSC-derived disease model